Short answer
ClearPoint Neuro, Inc. (CLPT) filed its Q1 2026 10-Q quarterly report on May 13, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $12M (up 42.9% year over year) with net income of −$10M.
Q1 2026 key financials · XBRL
- Revenue
- $12M
- +42.9% YoY
- Net income
- −$10M
- −58.5% YoY
- Operating margin
- -69.9%
- Gross margin
- 64.0%
- EPS (diluted)
- −$0.32
- −45.5% YoY
Source: XBRL data from the ClearPoint Neuro, Inc. (CLPT) Q1 2026 10-Q on SEC EDGAR. USD.
ClearPoint Neuro, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No risk-factors section provided in the submitted text
- IRRAS acquisition follow-on issuance: 7,885 shares issued to former equityholders after working-capital adjustment
- Securities-law compliance: shares issued under Section 4(a)(2) and/or Rule 506 exemptions
- No defaults upon senior securities reported
- No officer or director adopted or terminated trading arrangements during the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ClearPoint Neuro, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.